Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) FCF Payout Ratio (2021 - 2025)

Historic FCF Payout Ratio for Ani Pharmaceuticals (ANIP) over the last 5 years, with Q3 2025 value amounting to 0.01.

  • Ani Pharmaceuticals' FCF Payout Ratio fell 8289.43% to 0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01, marking a year-over-year decrease of 5258.12%. This contributed to the annual value of 0.03 for FY2024, which is 13040.75% up from last year.
  • As of Q3 2025, Ani Pharmaceuticals' FCF Payout Ratio stood at 0.01, which was down 8289.43% from 0.01 recorded in Q2 2025.
  • Over the past 5 years, Ani Pharmaceuticals' FCF Payout Ratio peaked at 0.35 during Q3 2022, and registered a low of 0.05 during Q4 2022.
  • Over the past 5 years, Ani Pharmaceuticals' median FCF Payout Ratio value was 0.01 (recorded in 2025), while the average stood at 0.03.
  • As far as peak fluctuations go, Ani Pharmaceuticals' FCF Payout Ratio plummeted by 25638.29% in 2022, and later surged by 29715.48% in 2024.
  • Quarter analysis of 5 years shows Ani Pharmaceuticals' FCF Payout Ratio stood at 0.02 in 2021, then tumbled by 256.38% to 0.05 in 2022, then skyrocketed by 117.71% to 0.01 in 2023, then soared by 215.32% to 0.03 in 2024, then crashed by 69.94% to 0.01 in 2025.
  • Its FCF Payout Ratio was 0.01 in Q3 2025, compared to 0.01 in Q2 2025 and 0.01 in Q1 2025.